pembrolizumab for patients with high-risk, non-muscle invasive bladder cancer
Published 2 years ago • 5 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
11:09
keytruda® for high-risk non-muscle invasive bladder cancer
-
3:02
updates from keynote 57: pembrolizumab for patients with bladder cancer
-
3:16
keynote-057 update: pembrolizumab for high-risk nmibc patients
-
19:21
immunotherapy for muscle invasive bladder cancer
-
4:51
expert video report on the management of patients with high-risk non-muscle invasive bladder cancer
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
4:28
very high risk non-muscle-invasive bladder cancer (nmibc) in the current landscape of nmibc
-
4:43
imvigor011: atezolizumab for ctdna-positive patients with high-risk muscle invasive bladder cancer
-
2:01
keynote-057 cohort b: pembrolizumab for bcg-unresponsive, high-risk nmibc
-
5:08
pembrolizumab shows notable anti-tumour activity for patients with high-risk nmibc
-
2:22
keynote-057: extended follow-up of pembrolizumab in bladder cancer
-
1:49
yair lotan, md, shares outcomes of keynote 057 in high-risk non-muscle-invasive bladder cancer
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
40:36
treatment paradigms for intermediate and high-risk non-muscle invasive bladder cancer
-
26:20
management of non-muscle invasive bladder cancer
-
13:32
conversations in high-risk non-muscle invasive bladder cancer
-
1:33
ambassador: pembrolizumab for locally advanced bladder cancer
-
2:21
novel treatments in muscle invasive and non-muscle invasive bladder cancer